Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Faculty Opinions recommendation of Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes. — Giuseppe Remuzzi | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Faculty Opinions recommendation of Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes.
Shared by
Giuseppe Remuzzi
Faculty Opinions recommendation of Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes.
Dataset
en
Authors
Giuseppe Remuzzi
AS
Arrigo Schieppati
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2006
Preventing microalbuminuria in patients with diabetes: rationale and design of the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study
Hermann Haller
,
Gian Carlo Viberti
,
A Mimran
,
Giuseppe Remuzzi
,
Ton J. Rabelink
,
Eberhard Ritz
,
Lars Christian Rump
,
Luís M. Ruilope
,
Shigehiro Katayama
,
Sadayoshi Ito
,
Joseph L. Izzo
,
Andrzej Januszewicz
Dataset
Faculty Opinions recommendation of Empagliflozin and progression of kidney disease in type 2 diabetes.
Giuseppe Remuzzi
,
Arrigo Schieppati
Dataset
Faculty Opinions recommendation of Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes.
Giuseppe Remuzzi
,
Amantia Imeraj
Article
2004
Preventing Microalbuminuria in Type 2 Diabetes
Piero Ruggenenti
,
Anna Fassi
,
Aneliya Parvanova
,
Simona Bruno
,
Ilian Iliev
,
Varusca Brusegan
,
Nadia Rubis
,
Giulia Gherardi
,
Federica Arnoldi
,
María Ganeva
,
Bogdan Ene‐Iordache
,
Flavio Gaspari
,
Annalisa Perna
,
Antonio Bossi
,
Roberto Trevisan
,
Alessandro Roberto Dodesini
,
Giuseppe Remuzzi
Dataset
Faculty Opinions recommendation of Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes.
Giuseppe Remuzzi
,
Arrigo Schieppati
.webp){kind=small}
Discussion(0)
No comments yet. Be the first to comment.